Particle Cloud

Particle Cloud focuses on providing advanced materials, innovative products, and intelligent equipment in the life health field. It has long been engaged in the core technology research and development of 3D printing regenerative artificial bone, establishing the world's first GMP production line for 3D printed artificial bone. The self-developed bioceramic 3D printer can accurately and personally customize artificial bones with biodegradable, osteoinductive physicochemical properties and bionic appearance structures. On February 2, 2018, it successfully conducted clinical trials at Xijing Hospital, achieving a significant breakthrough in the international challenge of personalized repair of load-bearing long-segment bone defects using 3D printing technology.